Literature DB >> 9414392

Expression of cyclin E in human gastric adenomas and adenocarcinomas: correlation with proliferative activity and p53 status.

W Yasui1, Y Akama, H Kuniyasu, H Yokozaki, S Semba, F Shimamoto, E Tahara.   

Abstract

The expression of cyclin E in human gastric adenomas and adenocarcinomas was examined immunohistochemically to elucidate the role of cyclin E in stomach carcinogenesis. The expression of cyclin E was detected in 49% (90/182) of the adenomas and 59% (260/439) of the adenocarcinomas. The incidence of strongly positive cases (overexpression of cyclin E) was significantly higher in the adenocarcinomas (29%; 128/439) than in the adenomas (4%; 8/182) (p < 0.01). The incidence of the cyclin E expression showed a tendency to be higher in deeply invasive carcinomas and in the cases with lymph node metastasis, while the incidence did not differ among histological types. The expression of cyclin E was significantly correlated with the proliferative activity of the tumor cells measured by KI-67 antigen expression (p < 0.01). It was also correlated with the abnormal accumulation of p53 protein in the tumor cells (p < 0.01). These results suggest that overexpression of cyclin E and subsequent deregulation of the cell cycle may confer the development and progression of the gastric carcinomas.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9414392

Source DB:  PubMed          Journal:  J Exp Ther Oncol        ISSN: 1359-4117


  11 in total

1.  Approach to early-onset colorectal cancer: clinicopathological, familial, molecular and immunohistochemical characteristics.

Authors:  Jose Perea; Edurne Alvaro; Yolanda Rodríguez; Cristina Gravalos; Eva Sánchez-Tomé; Barbara Rivera; Francisco Colina; Pablo Carbonell; Rogelio González-Sarmiento; Manuel Hidalgo; Miguel Urioste
Journal:  World J Gastroenterol       Date:  2010-08-07       Impact factor: 5.742

Review 2.  Low-Molecular-Weight Cyclin E in Human Cancer: Cellular Consequences and Opportunities for Targeted Therapies.

Authors:  Joseph A Caruso; Mylinh T Duong; Jason P W Carey; Kelly K Hunt; Khandan Keyomarsi
Journal:  Cancer Res       Date:  2018-09-07       Impact factor: 12.701

3.  Expression of cyclin E in colorectal adenomas and adenocarcinomas: correlation with expression of Ki-67 antigen and p53 protein.

Authors:  W Yasui; H Kuniyasu; H Yokozaki; S Semba; F Shimamoto; E Tahara
Journal:  Virchows Arch       Date:  1996-09       Impact factor: 4.064

4.  Does the expression of cyclin E, pRb, and p21 correlate with prognosis in gastric adenocarcinoma?

Authors:  Gregory Kouraklis; Iraklis E Katsoulis; Stamatios Theocharis; Gerasimos Tsourouflis; Nikos Xipolitas; Andromahi Glinavou; Chrysa Sioka; Alkiviadis Kostakis
Journal:  Dig Dis Sci       Date:  2008-12-05       Impact factor: 3.199

5.  Cyclins and cell cycle control in cancer and disease.

Authors:  Mathew C Casimiro; Marco Crosariol; Emanuele Loro; Zhiping Li; Richard G Pestell
Journal:  Genes Cancer       Date:  2012-11

6.  Expression of G1 phase cyclins in human gastric cancer and gastric mucosa of first-degree relatives.

Authors:  Stephan Miehlke; Jun Yu; Matthias Ebert; Daniel Szokodi; Michael Vieth; Eberhard Kuhlisch; Rene Buchcik; Wolfgang Schimmin; Ursula Wehrmann; Peter Malfertheiner; Gerhard Ehninger; Ekkehard Bayerdörffer; Manfred Stolte
Journal:  Dig Dis Sci       Date:  2002-06       Impact factor: 3.199

Review 7.  Cell cyclins: triggering elements of cancer or not?

Authors:  Michael Stamatakos; Victoria Palla; Ioannis Karaiskos; Konstantinos Xiromeritis; Ioannis Alexiou; Ioannis Pateras; Konstantinos Kontzoglou
Journal:  World J Surg Oncol       Date:  2010-12-22       Impact factor: 2.754

8.  Construction and Antiapoptosis Activities of Recombinant Adenoviral Expression Vector Carrying EBV Latent Membrane Protein 2A.

Authors:  Xishuang Liu; Yu Gao; Bing Luo; Youan Zhao
Journal:  Gastroenterol Res Pract       Date:  2011-08-16       Impact factor: 2.260

9.  USP27-mediated Cyclin E stabilization drives cell cycle progression and hepatocellular tumorigenesis.

Authors:  Ling Dong; Le Yu; Chunrong Bai; Liu Liu; Hua Long; Lei Shi; Zhenghong Lin
Journal:  Oncogene       Date:  2018-03-02       Impact factor: 9.867

10.  Reduced expression of cyclin-dependent kinase inhibitor p27Kip1 is associated with advanced stage and invasiveness of gastric carcinomas.

Authors:  W Yasui; Y Kudo; S Semba; H Yokozaki; E Tahara
Journal:  Jpn J Cancer Res       Date:  1997-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.